FdaApplication

NDA 021073

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date1999-07-15

Products (3)

ProductActive ingredientStrengthDosage form
ACTOSPIOGLITAZONE HYDROCHLORIDEEQ 45MG BASETABLET;ORAL
ACTOSPIOGLITAZONE HYDROCHLORIDEEQ 30MG BASETABLET;ORAL
ACTOSPIOGLITAZONE HYDROCHLORIDEEQ 15MG BASETABLET;ORAL

3 products